Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A deep-learning workflow to predict upper tract urothelial cancer subtypes supporting the prioritization of patients for molecular testing

View ORCID ProfileMiriam Angeloni, View ORCID ProfileThomas van Doeveren, Sebastian Lindner, Patrick Volland, Jorina Schmelmer, View ORCID ProfileSebastian Foersch, View ORCID ProfileChristian Matek, View ORCID ProfileRobert Stoehr, Carol I. Geppert, View ORCID ProfileHendrik Heers, View ORCID ProfileSven Wach, View ORCID ProfileHelge Taubert, View ORCID ProfileDanijel Sikic, View ORCID ProfileBernd Wullich, View ORCID ProfileGeert J. L. H. van Leenders, View ORCID ProfileVasily Zaburdaev, View ORCID ProfileMarkus Eckstein, View ORCID ProfileArndt Hartmann, Joost L. Boormans, View ORCID ProfileFulvia Ferrazzi, Veronika Bahlinger
doi: https://doi.org/10.1101/2023.06.14.23291350
Miriam Angeloni
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Miriam Angeloni
Thomas van Doeveren
4Department of Urology, Erasmus MC Urothelial Cancer Research Group, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas van Doeveren
Sebastian Lindner
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Volland
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jorina Schmelmer
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Foersch
6Institute of Pathology, University Medical Center Mainz, Mainz, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sebastian Foersch
Christian Matek
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christian Matek
Robert Stoehr
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert Stoehr
Carol I. Geppert
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrik Heers
7Department of Urology, Philipps-Universität Marburg, Marburg, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hendrik Heers
Sven Wach
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
8Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sven Wach
Helge Taubert
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
8Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helge Taubert
Danijel Sikic
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
8Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Danijel Sikic
Bernd Wullich
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
8Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bernd Wullich
Geert J. L. H. van Leenders
9Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Geert J. L. H. van Leenders
Vasily Zaburdaev
10Department of Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
11Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vasily Zaburdaev
Markus Eckstein
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Markus Eckstein
Arndt Hartmann
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arndt Hartmann
Joost L. Boormans
4Department of Urology, Erasmus MC Urothelial Cancer Research Group, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fulvia Ferrazzi
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
5Department of Nephropathology, Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fulvia Ferrazzi
  • For correspondence: fulvia.ferrazzi{at}uk-erlangen.de
Veronika Bahlinger
1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fulvia.ferrazzi{at}uk-erlangen.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2023.06.14.23291350
History 
  • June 22, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Miriam Angeloni1,2,3,
  2. Thomas van Doeveren4,
  3. Sebastian Lindner1,2,3,
  4. Patrick Volland1,2,3,
  5. Jorina Schmelmer1,2,3,
  6. Sebastian Foersch6,
  7. Christian Matek1,2,3,
  8. Robert Stoehr1,2,3,
  9. Carol I. Geppert1,2,3,
  10. Hendrik Heers7,
  11. Sven Wach2,3,8,
  12. Helge Taubert2,3,8,
  13. Danijel Sikic2,3,8,
  14. Bernd Wullich2,3,8,
  15. Geert J. L. H. van Leenders9,
  16. Vasily Zaburdaev10,11,
  17. Markus Eckstein1,2,3,
  18. Arndt Hartmann1,2,3,
  19. Joost L. Boormans4,
  20. Fulvia Ferrazzi1,2,3,5,†,* and
  21. Veronika Bahlinger1,2,3,†,*
  1. 1Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  2. 2Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany
  3. 3Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  4. 4Department of Urology, Erasmus MC Urothelial Cancer Research Group, Rotterdam, The Netherlands
  5. 5Department of Nephropathology, Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  6. 6Institute of Pathology, University Medical Center Mainz, Mainz, Germany.
  7. 7Department of Urology, Philipps-Universität Marburg, Marburg, Germany.
  8. 8Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany
  9. 9Department of Pathology, Erasmus MC Cancer Institute, University Medical Centre, Rotterdam, the Netherlands
  10. 10Department of Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
  11. 11Max-Planck-Zentrum für Physik und Medizin, Erlangen, Germany
  1. ↵*Corresponding authors:
    Fulvia Ferrazzi, PhD Department of Nephropathology, Institute of Pathology Friedrich-Alexander-Universität Erlangen- Nürnberg Krankenhausstr. 8-10, 91054 Erlangen, Germany E-mail: fulvia.ferrazzi{at}uk-erlangen.de; Tel. +49-9131-8543677
  2. Veronika Bahlinger, MD Institute of Pathology Friedrich-Alexander-Universität Erlangen-Nürnberg Krankenhausstr. 8-10, 91054 Erlangen, Germany E-mail: veronika.bahlinger{at}uk-erlangen.de; Tel. +49-9131-8547791
  1. ↵† These authors share co-senior authorship.

Back to top
PreviousNext
Posted June 22, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A deep-learning workflow to predict upper tract urothelial cancer subtypes supporting the prioritization of patients for molecular testing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A deep-learning workflow to predict upper tract urothelial cancer subtypes supporting the prioritization of patients for molecular testing
Miriam Angeloni, Thomas van Doeveren, Sebastian Lindner, Patrick Volland, Jorina Schmelmer, Sebastian Foersch, Christian Matek, Robert Stoehr, Carol I. Geppert, Hendrik Heers, Sven Wach, Helge Taubert, Danijel Sikic, Bernd Wullich, Geert J. L. H. van Leenders, Vasily Zaburdaev, Markus Eckstein, Arndt Hartmann, Joost L. Boormans, Fulvia Ferrazzi, Veronika Bahlinger
medRxiv 2023.06.14.23291350; doi: https://doi.org/10.1101/2023.06.14.23291350
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A deep-learning workflow to predict upper tract urothelial cancer subtypes supporting the prioritization of patients for molecular testing
Miriam Angeloni, Thomas van Doeveren, Sebastian Lindner, Patrick Volland, Jorina Schmelmer, Sebastian Foersch, Christian Matek, Robert Stoehr, Carol I. Geppert, Hendrik Heers, Sven Wach, Helge Taubert, Danijel Sikic, Bernd Wullich, Geert J. L. H. van Leenders, Vasily Zaburdaev, Markus Eckstein, Arndt Hartmann, Joost L. Boormans, Fulvia Ferrazzi, Veronika Bahlinger
medRxiv 2023.06.14.23291350; doi: https://doi.org/10.1101/2023.06.14.23291350

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Urology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)